SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2000-Year of the Biotechs!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (1108)11/15/2000 7:16:37 PM
From: opalapril  Read Replies (1) of 1142
 
Everything depends on the FDA vote, of course, but I like GNLB. (At least the FDA won't be trying to punch holes in a paper ballot -- will it??)

The data from P2 looks good. There is no immediate competition. The Lupus indication is large and chronic, thus likely to yield continuing sales. They have some other promising cancer stuff coming along, too.

I was going to urge you to include it in your forthcoming "2001 Biotechs" board but the g'ummint may surprise us and act early.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News